Balance Sheet SoftMedx Healthcare Limited

Stocks

648 HK0001311726

Leisure & Recreation

End-of-day quote Hong Kong S.E. Other stock markets 2026-06-11			5-day change	1st Jan Change
2.470 ^HKD	-14.24%		+80.29%	-33.60%

May. 17	SoftMedx Healthcare's Controlling Shareholder Completes Share Sale; Shares Up 5%	MT
May. 07	SoftMedx Healthcare's Controlling Shareholder Completes Share Sale	MT

fdae976be8e74a578ccb2771b14.WhF2dxXdaOAR-QDSKzwHH6sCUX4JgU3fT8-ZWtMlezc.bFYDEmS2GYV4ljm2antlXvltJiFEuR_oHfz0EolhDEYMaBBCY5ZQqXy-OA

Published financial data: SOFTMEDX HEALTHCARE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.7M	33.76M	51.34M	54.64M	68.24M
Total Revenues	1.7M	33.76M	51.34M	54.64M	68.24M
Cost of Goods Sold, Total	909K	20.03M	30.22M	36.24M	45.65M
Gross Profit	790K	13.74M	21.12M	18.4M	22.59M
Selling General & Admin Expenses, Total	21.84M	23.02M	15.09M	9.84M	11.07M
Provision for Bad Debts	-	-	-	-	-
Other Operating Expenses, Total	21.84M	23.02M	15.09M	9.84M	11.07M
Operating Income	-21.05M	-9.28M	6.04M	8.56M	11.52M
Interest Expense, Total	-16.27M	-15.55M	-12.94M	-1.32M	-1.4M
Interest And Investment Income	1K	38K	363K	188K	68K
Net Interest Expenses	-16.27M	-15.51M	-12.58M	-1.13M	-1.33M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	4.2M	8.04M	-
Other Non Operating Income (Expenses)	7.39M	9.02M	2.36M	1.07M	2.09M
EBT, Excl. Unusual Items	-29.93M	-15.78M	19K	16.54M	12.28M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-2.74M	-725K	19.08M	-16.61M	-2.82M
Gain (Loss) On Sale Of Assets	7.95M	-	-4.72M	-	-
Asset Writedown	-	-345K	-	-	-
Other Unusual Items	-	216K	-	328M	-20K
EBT, Incl. Unusual Items	-24.72M	-16.63M	14.37M	328M	9.45M
Income Tax Expense	-	2.59M	1.86M	1.64M	2.5M
Earnings From Continuing Operations	-24.72M	-19.22M	12.51M	326M	6.95M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-24.72M	-19.22M	12.51M	326M	6.95M
Minority Interest	-1.56M	-	-	-	-
Net Income - (IS)	-26.28M	-19.22M	12.51M	326M	6.95M
Net Income to Common Incl Extra Items	-26.28M	-19.22M	12.51M	326M	6.95M
Net Income to Common Excl. Extra Items	-26.28M	-19.22M	12.51M	326M	6.95M
Per Share Items
Net EPS - Basic	-1.61	-1.18	0.77	20.02	0.24
Basic EPS - Continuing Operations	-1.61	-1.18	0.77	20.02	0.24
Basic Weighted Average Shares Outstanding	16.3M	16.3M	16.3M	16.3M	28.88M
Net EPS - Diluted	-1.61	-1.18	0.77	20.02	0.24
Diluted EPS - Continuing Operations	-1.61	-1.18	0.77	20.02	0.24
Diluted Weighted Average Shares Outstanding	16.3M	16.3M	16.3M	16.3M	28.88M
Normalized Basic EPS	-1.24	-0.6	0	0.63	0.27
Normalized Diluted EPS	-1.24	-0.6	0	0.63	0.27
Supplemental Items
EBITDA	-20.83M	-8.95M	6.26M	8.73M	11.59M
EBITA	-21.05M	-9.28M	6.04M	8.56M	11.52M
EBIT	-21.05M	-9.28M	6.04M	8.56M	11.52M
EBITDAR	-	-	7.24M	10.41M	13.46M
Effective Tax Rate - (Ratio)	-	-15.59	12.93	0.5	26.44
Current Domestic Taxes	-	2.59M	1.86M	1.64M	2.5M
Total Current Taxes	-	2.59M	1.86M	1.64M	2.5M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-20.26M	-9.86M	11.88K	10.34M	7.68M
Interest on Long-Term Debt	3.34M	100K	2.96M	36K	42K
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	21.84M	23.02M	15.09M	9.84M	11.07M
Net Rental Expense, Total	-	-	972K	1.68M	1.87M
Imputed Operating Lease Interest Expense	-	-	355K	109K	895K
Imputed Operating Lease Depreciation	-	-	617K	1.57M	974K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.67M	3.1M	8.07M	8.77M	12.03M
Short Term Investments	6.52M	1.25M	519K	740K	5.71M
Trading Asset Securities, Total	-	22K	-	-	-
Total Cash And Short Term Investments	10.19M	4.36M	8.59M	9.51M	17.74M
Accounts Receivable, Total	1.66M	1.04M	7.11M	16.74M	15.08M
Other Receivables	-	-	-	-	-
Total Receivables	1.66M	1.04M	7.11M	16.74M	15.08M
Inventory	-	1.97M	2.83M	4.78M	5.44M
Prepaid Expenses	177K	20K	27K	21K	33K
Other Current Assets, Total	-	11.21M	16.55M	18.76M	9.77M
Total Current Assets	12.03M	18.6M	35.1M	49.81M	48.06M
Gross Property Plant And Equipment	5.5M	5.51M	4.86M	5.53M	4.29M
Accumulated Depreciation	-3.86M	-4.19M	-4.42M	-4.59M	-3.77M
Net Property Plant And Equipment	1.64M	1.32M	448K	940K	515K
Long-term Investments	5.44M	4.71M	20.53M	3.92M	-
Goodwill	-	-	-	-	-
Other Intangibles, Total	-	-	-	-	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	19.12M	24.64M	56.07M	54.67M	48.58M
Liabilities
Accounts Payable, Total	-	-	-	10.08M	2.95M
Accrued Expenses, Total	50.05M	62.74M	63.1M	204K	456K
Short-term Borrowings	-	57.89M	-	-	-
Current Portion of Long-Term Debt	195M	216M	288M	33.11M	12.1M
Current Portion of Leases	1.08M	889K	211K	363K	384K
Current Income Taxes Payable	102K	2.44M	2.96M	4.68M	4.03M
Unearned Revenue Current, Total	-	2.32M	781K	270K	201K
Other Current Liabilities	20.86M	24.57M	22.08M	2.95M	886K
Total Current Liabilities	267M	366M	377M	51.66M	21M
Long-Term Debt	76.68M	2.19M	3.25M	-	-
Long-Term Leases	-	-	-	551K	167K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	344M	369M	380M	52.21M	21.17M
Common Stock, Total	3.03B	3.03B	3.03B	3.03B	3.05B
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-	-3.37B	-3.35B	-3.03B	-3.02B
Comprehensive Income and Other	-3.35B	-	-	-	-
Total Common Equity	-317M	-336M	-324M	2.46M	27.41M
Minority Interest	-7.58M	-7.58M	-	-	-
Total Equity	-325M	-344M	-324M	2.46M	27.41M
Total Liabilities And Equity	19.12M	24.64M	56.07M	54.67M	48.58M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.3M	16.3M	16.3M	16.3M	106M
ECS Total Common Shares Outstanding	16.3M	16.3M	16.3M	16.3M	106M
Book Value / Share	-19.47	-20.63	-19.87	0.15	0.26
Tangible Book Value	-317M	-336M	-324M	2.46M	27.41M
Tangible Book Value Per Share	-19.47	-20.63	-19.87	0.15	0.26
Total Debt	273M	277M	291M	34.03M	12.65M
Net Debt	263M	272M	282M	24.51M	-5.09M
Debt Equivalent Oper. Leases	-	-	7.78M	13.42M	14.95M
Minority Interest, Total (Incl. Fin. Div)	-7.58M	-7.58M	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	-	5	5	5
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	1.97M	2.83M	4.78M	5.44M
Land - (BS)	-	-	-	-	-
Machinery, Total	4M	4.53M	4.53M	4.53M	3.65M
Full Time Employees	8	17	22	19	20
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-26.28M	-19.22M	12.51M	326M	6.95M
Depreciation & Amortization - CF	1.19M	2.04M	1.19M	592K	425K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	1.19M	2.04M	1.19M	592K	425K
(Gain) Loss From Sale Of Asset	-7.95M	-	4.72M	-	-
(Gain) Loss on Sale of Investments - (CF)	2.74M	725K	-19.08M	16.61M	2.82M
Asset Writedown & Restructuring Costs	-	345K	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	10.76M	11.22M	8.9M	-333M	2.38M
Change in Trading Asset Securities	-	-	-	-	-
Change In Accounts Receivable	1.38M	628K	-10.03M	-9.63M	1.66M
Change In Inventories	-	-1.97M	-860K	-1.95M	-657K
Change In Accounts Payable	-	9.69M	3.53M	7.59M	-9.04M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	11.54M	-6.3M	-5.38M	-2.43M	861K
Cash from Operations	-6.62M	-2.84M	-4.49M	3.88M	5.4M
Capital Expenditure	-524K	-532K	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-734K	-	-52K	-	-
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	561K	-	-1.16M	-	1.1M
Other Investing Activities, Total	-	-	363K	188K	68K
Cash from Investing	-697K	-532K	-845K	188K	1.17M
Long-Term Debt Issued, Total	17.05M	7.24M	13.53M	25.03M	1.08M
Total Debt Issued	17.05M	7.24M	13.53M	25.03M	1.08M
Long-Term Debt Repaid, Total	-7.07M	-4.55M	-3.18M	-28.35M	-4.35M
Total Debt Repaid	-7.07M	-4.55M	-3.18M	-28.35M	-4.35M
Issuance of Common Stock	-	203K	-	-	-
Other Financing Activities, Total	-71K	-100K	-37K	-36K	-42K
Cash from Financing	9.91M	2.8M	10.31M	-3.36M	-3.31M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	2.6M	-575K	4.97M	705K	3.25M
Supplemental Items
Cash Interest Paid	71K	100K	37K	36K	42K
Cash Income Tax Paid (Refund)	-	255K	1.33M	-75K	-
Levered Free Cash Flow	-23.06M	-5.35M	-18.55M	-79.41M	615K
Unlevered Free Cash Flow	-12.89M	4.36M	-10.46M	-78.58M	1.49M
Change In Net Working Capital	403K	-8.66M	15.42M	84.52M	6.14M
Net Debt Issued / Repaid	9.98M	2.7M	10.34M	-3.33M	-3.27M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-56.69	-26.52	9.35	9.66	13.95
Return on Total Capital	24.7	9.72	-7.53	294.31	18.82
Return On Equity %	7.71	5.75	-3.75	-203.06	46.55
Return on Common Equity	8.64	5.88	-3.79	-203.06	46.55
Margin Analysis
Gross Profit Margin %	46.5	40.68	41.15	33.67	33.11
SG&A Margin	1.29K	68.18	29.39	18	16.22
EBITDA Margin %	-1.23K	-26.51	12.2	15.98	16.98
EBITA Margin %	-1.24K	-27.5	11.76	15.67	16.89
EBIT Margin %	-1.24K	-27.5	11.76	15.67	16.89
Income From Continuing Operations Margin %	-1.45K	-56.94	24.37	597.22	10.18
Net Income Margin %	-1.55K	-56.94	24.37	597.22	10.18
Net Avail. For Common Margin %	-1.55K	-56.94	24.37	597.22	10.18
Normalized Net Income Margin	-1.19K	-29.21	0.02	18.92	11.25
Levered Free Cash Flow Margin	-1.36K	-15.86	-36.13	-145.33	0.9
Unlevered Free Cash Flow Margin	-758.53	12.92	-20.37	-143.82	2.18
Asset Turnover
Asset Turnover	0.07	1.54	1.27	0.99	1.32
Fixed Assets Turnover	0.34	22.78	58.04	78.73	93.8
Receivables Turnover (Average Receivables)	1.86	24.99	12.61	4.58	4.29
Inventory Turnover (Average Inventory)	-	-	12.59	9.52	8.93
Short Term Liquidity
Current Ratio	0.04	0.05	0.09	0.96	2.29
Quick Ratio	0.04	0.01	0.04	0.51	1.56
Operating Cash Flow to Current Liabilities	-0.02	-0.01	-0.01	0.08	0.26
Days Sales Outstanding (Average Receivables)	195.71	14.6	28.95	79.87	85.1
Days Outstanding Inventory (Average Inventory)	-	-	28.99	38.43	40.85
Average Days Payable Outstanding	-	-	-	-	51.35
Cash Conversion Cycle (Average Days)	-	-	-	-	74.61
Long Term Solvency
Total Debt/Equity	-84.03	-80.4	-89.86	1.39K	46.16
Total Debt / Total Capital	-526.08	-410.08	-885.97	93.27	31.58
LT Debt/Equity	-23.6	-0.64	-1	22.43	0.61
Long-Term Debt / Total Capital	-147.74	-3.24	-9.88	1.51	0.42
Total Liabilities / Total Assets	1.8K	1.5K	677.57	95.51	43.58
EBIT / Interest Expense	-1.29	-0.6	0.47	6.48	8.25
EBITDA / Interest Expense	-1.22	-0.47	0.56	6.93	8.55
(EBITDA - Capex) / Interest Expense	-1.25	-0.5	0.56	6.93	8.55
Total Debt / EBITDA	-13.75	-38.17	40.27	3.72	1.06
Net Debt / EBITDA	-13.24	-37.57	39.08	2.68	-0.43
Total Debt / (EBITDA - Capex)	-13.4	-35.56	40.27	3.72	1.06
Net Debt / (EBITDA - Capex)	-12.9	-35	39.08	2.68	-0.43
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-82.33	1.89K	52.05	6.43	24.9
Gross Profit, 1 Yr. Growth %	-84.88	1.64K	53.78	-12.91	22.8
EBITDA, 1 Yr. Growth %	-34.34	-57.04	-169.97	39.42	32.71
EBITA, 1 Yr. Growth %	-34.6	-55.89	-165.04	41.79	34.61
EBIT, 1 Yr. Growth %	-34.6	-55.89	-165.04	41.79	34.61
Earnings From Cont. Operations, 1 Yr. Growth %	-52.89	-22.22	-165.08	2.51K	-97.87
Net Income, 1 Yr. Growth %	-48.32	-26.83	-165.08	2.51K	-97.87
Normalized Net Income, 1 Yr. Growth %	-29.32	-51.33	-100.12	86.96K	-25.74
Diluted EPS Before Extra, 1 Yr. Growth %	-48.32	-26.83	-165.08	2.51K	-98.8
Accounts Receivable, 1 Yr. Growth %	960.51	-37.72	585.44	135.5	-9.89
Inventory, 1 Yr. Growth %	-	-	43.65	68.94	13.74
Net Property, Plant and Equip., 1 Yr. Growth %	-80.13	-19.65	-66.09	109.82	-45.21
Total Assets, 1 Yr. Growth %	-29.97	28.9	127.57	-2.51	-11.14
Tangible Book Value, 1 Yr. Growth %	9.03	5.99	-3.72	-100.76	1.02K
Common Equity, 1 Yr. Growth %	9.03	5.99	-3.72	-100.76	1.02K
Cash From Operations, 1 Yr. Growth %	-32.94	-57.04	57.93	-186.44	39.09
Capital Expenditures, 1 Yr. Growth %	-	1.53	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	130.27	-76.78	246.37	328.14	-100.84
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.09K	-133.86	-339.7	651.31	-102.06
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-79.43	87.38	449.71	27.21	15.29
Gross Profit, 2 Yr. CAGR %	-81.46	62.14	417.11	15.73	3.42
EBITDA, 2 Yr. CAGR %	-29.76	-46.89	-45.17	-1.23	36.02
EBITA, 2 Yr. CAGR %	-30.56	-46.29	-46.44	-3.97	38.15
EBIT, 2 Yr. CAGR %	-30.56	-46.29	-46.44	-3.97	38.15
Earnings From Cont. Operations, 2 Yr. CAGR %	-44.11	-39.47	-28.85	311.99	-25.47
Net Income, 2 Yr. CAGR %	-41.58	-38.51	-31	311.99	-25.47
Normalized Net Income, 2 Yr. CAGR %	-21.25	-41.35	-97.58	2.39	2.44K
Diluted EPS Before Extra, 2 Yr. CAGR %	-41.58	-38.51	-31	311.99	-44
Accounts Receivable, 2 Yr. CAGR %	38.26	157	106.62	301.77	45.67
Inventory, 2 Yr. CAGR %	-	-40.1	-	55.79	38.62
Net Property, Plant and Equip., 2 Yr. CAGR %	-59.84	-60.05	-47.8	-15.64	7.22
Total Assets, 2 Yr. CAGR %	-32.3	-4.99	71.27	48.95	-6.92
Tangible Book Value, 2 Yr. CAGR %	13.75	7.5	1.02	-91.46	-70.91
Common Equity, 2 Yr. CAGR %	14.94	7.5	1.02	-91.46	-70.91
Cash From Operations, 2 Yr. CAGR %	-36.06	-46.33	-17.63	16.84	9.65
Capital Expenditures, 2 Yr. CAGR %	79.3	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	31.41	-26.87	-10.31	285.09	-81.78
Unlevered Free Cash Flow, 2 Yr. CAGR %	120.08	83.16	-9.91	324.37	-62.28
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-69.21	-5.62	74.77	218.01	26.43
Gross Profit, 3 Yr. CAGR %	-70.53	-15.78	59.31	185.57	18.04
EBITDA, 3 Yr. CAGR %	-25.32	-40.37	-41.78	-25.16	8.99
EBITA, 3 Yr. CAGR %	-26.33	-40.31	-42.75	-25.91	7.47
EBIT, 3 Yr. CAGR %	-26.33	-40.31	-42.75	-25.91	7.47
Earnings From Cont. Operations, 3 Yr. CAGR %	-27.42	-37.6	-37.99	136.35	-28.76
Net Income, 3 Yr. CAGR %	-26.46	-37.03	-37.34	131.58	-28.76
Normalized Net Income, 3 Yr. CAGR %	-21.84	-32.92	-92.55	-20.09	-8.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-26.46	-37.03	-37.34	131.58	-41.12
Accounts Receivable, 3 Yr. CAGR %	-20.9	5.99	256.41	115.83	144.11
Inventory, 3 Yr. CAGR %	-	-35.2	-19.82	-	40.28
Net Property, Plant and Equip., 3 Yr. CAGR %	-26.85	-49.39	-62.17	-17	-26.95
Total Assets, 3 Yr. CAGR %	-53.59	-16.09	27.12	41.94	25.39
Tangible Book Value, 3 Yr. CAGR %	54.25	11.1	3.62	-80.22	-56.65
Common Equity, 3 Yr. CAGR %	62.73	11.87	3.62	-80.22	-56.65
Cash From Operations, 3 Yr. CAGR %	-31.6	-44	-23.09	-16.3	23.83
Capital Expenditures, 3 Yr. CAGR %	0.06	48.33	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	76.29	-26.25	22.81	51.02	-51.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.4	17.93	100.35	82.69	-30.13
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-55.89	-22.47	-2.49	6.35	47.98
Gross Profit, 5 Yr. CAGR %	-53.22	-21.71	-7.3	-4.36	34.02
EBITDA, 5 Yr. CAGR %	-25.24	-34.91	-34	-27.04	-18.25
EBITA, 5 Yr. CAGR %	-26.43	-35.29	-35.15	-27.8	-18.57
EBIT, 5 Yr. CAGR %	-26.7	-35.44	-35.15	-27.8	-18.57
Earnings From Cont. Operations, 5 Yr. CAGR %	-40.84	-38.74	-28	32.76	-33.26
Net Income, 5 Yr. CAGR %	-39.01	-39.05	-28.31	33.49	-32.83
Normalized Net Income, 5 Yr. CAGR %	-14.68	-28.02	-80.54	-20.56	-23.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-44.88	-37.89	-28.31	33.49	-40.09
Accounts Receivable, 5 Yr. CAGR %	-41.88	-11.74	16.14	80.61	149.19
Inventory, 5 Yr. CAGR %	-	-29.31	-24	-7.96	-0.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-50.91	-27.32	-36.08	-37.92	-42.61
Total Assets, 5 Yr. CAGR %	-53.45	-39.79	-21.75	5.56	12.22
Tangible Book Value, 5 Yr. CAGR %	23.96	78.22	30.23	-60.18	-37.66
Common Equity, 5 Yr. CAGR %	5.24	124.53	34.47	-60.01	-37.66
Cash From Operations, 5 Yr. CAGR %	-41.54	-44.61	-26.32	-24.85	-11.37
Capital Expenditures, 5 Yr. CAGR %	-41.77	-39.14	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-23.98	-48.32	34.54	42.85	-42.76
Unlevered Free Cash Flow, 5 Yr. CAGR %	-29.19	-48.86	-9.01	96.82	2.74